Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu
Poster De Conférence Année : 2022

Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis

Domaines

Immunologie
Bayer Alexandra Myology 2022 Nice.pdf (68.92 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03824304 , version 1 (21-10-2022)

Identifiants

  • HAL Id : hal-03824304 , version 1

Citer

Alexandra Bayer Wildberger, Cinthia Bergman, Natalia Pinzon, Axel You, Frédérique Truffault, et al.. Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis. 7th International Myology Congress, Sep 2022, Nice, France. ⟨hal-03824304⟩
44 Consultations
17 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More